Colleen Badgley

Partner
Full contact info

Experience

Andreessen Horowitz Leads Slingshot AI’s Seed Financing

August 20, 2024

Cooley advised Andreessen Horowitz (a16z), a Silicon Valley-based venture capital firm that backs bold entrepreneurs building the future through technology, as the lead investor in Slingshot AI’s approximately $30 million seed financing.

Read more

Related contacts

Josh Seidenfeld
Partner, Palo Alto
Colleen Badgley
Partner, Seattle
Alexis Finkelberg Bortniker
Partner, San Diego
Paula Holland
Partner, London
David Navetta
Partner, Colorado
Tracy Rubin
Partner, Palo Alto
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Thomas Heiser
Associate, Palo Alto
Wyatt Kernell
Associate, Colorado
Allison Kutner
Associate, New York
Leo Spicer-Phelps
Associate, London
Nicholas Yacoubian
Associate, Palo Alto
Kevin Gurley
Quantitative Analyst, New York

Related Practices & Industries

Outpace Bio Announces $144 Million Oversubscribed Series B

August 1, 2024

Cooley advised Outpace Bio, a cell therapy company using unrivaled artificial intelligence-powered protein design to program immune cells for improved function inside patients battling solid tumors, on its $144 million oversubscribed Series B financing.

Read more

Related contacts

Colleen Badgley
Partner, Seattle
Sonya Erickson
Partner and Business Department Chair, Seattle
Christopher Kimball
Partner, Washington, DC
Mika Reiner Mayer
Partner, Palo Alto
John Sellers
Partner, Palo Alto
Timothy Shapiro
Partner, Palo Alto
Dillon Martinson
Special Counsel, Washington, DC
Rebecca Ross
Special Counsel, Washington, DC
Lucy Bauer
Associate, Seattle
Karen Gustavson
Associate, Seattle
Millie Heuer
Associate, Seattle
Brian Woodard
Paralegal Specialist, Seattle
Katie Kissner
Quantitative Analyst, San Francisco

Related Practices & Industries

ARCH Venture Partners Co-Leads Xaira Therapeutics $1 Billion Series A Funding

April 24, 2024

Cooley advised ARCH Venture Partners, which co-led a $1 billion Series A funding round in Xaira Therapeutics. Partners Colleen Badgley, Danielle Naftulin and Dave Peinsipp led the Cooley team advising ARCH, a venture capital firm catalyzing discoveries that prevent, detect and cure disease.

Related contacts

David Peinsipp
Partner, San Francisco
Colleen Badgley
Partner, Seattle
Danielle Naftulin
Partner, Palo Alto
Willy Cowles
Associate, Seattle
Bill Christiansen
Partner, Seattle
Dr. Tian Yong Zheng
Patent Agent, Seattle
Chen Chen
Associate, Palo Alto
Bin Wang
Special Counsel, Palo Alto
Zack Gong
Associate, Shanghai
Tom James
Associate, San Francisco
Thomas Welk
Senior Counsel, San Diego
Carly Robinson
Associate, Reston
Sharon Connaughton
Special Counsel, Washington, DC
Elizabeth M. Morrison
Associate, Boston

Related Practices & Industries

Kimia Therapeutics Closes $55 Million Series A

December 19, 2023

Cooley advised Kimia Therapeutics on its $55 million Series A financing. Partner Josh Seidenfeld led the Cooley team advising Kimia Therapeutics, which is a drug discovery platform that uncovers novel biological insights through precision chemistry and machine learning.

Read more

Related contacts

Josh Seidenfeld
Partner, Palo Alto
Karen Gustavson
Associate, Seattle
Rachel Robichaux
Associate, Palo Alto
Phoebe Huang
Associate, Seattle
Meg Begur
Associate, Washington, DC
Colleen Badgley
Partner, Seattle

Related Practices & Industries

Parse Biosciences Closes $50 Million Series C

December 14, 2023

Cooley advised Parse Biosciences on its $50 million Series C financing. Partner Sonya Erickson led the Cooley team advising Parse Biosciences, which develops single-cell sequencing products used by more than 1,000 labs worldwide.

Read more

Related contacts

Sonya Erickson
Partner and Business Department Chair, Seattle
Lucy Bauer
Associate, Seattle
Willy Cowles
Associate, Seattle
Yuri Weigel
Special Counsel, Seattle
Scott Lin
Associate, San Francisco
Colleen Badgley
Partner, Seattle

Related Practices & Industries

View more

Admissions and credentials

Washington